Decreased peritoneal concentrations of interleukin-15 in women with advanced stage endometriosis

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 129, Issue 2, 2006, Pages 169-173

  Lin, Jun ^a   Zhang, Xinmei ^a   Lin, Deng ^a   Fang, Qingxian ^a   Qian, Yuli ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cytokine; Endometriosis; Interleukin 15; Peritoneal fluid

Indexed keywords

INTERLEUKIN 15;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIOSIS; FEMALE; HUMAN; MENSTRUAL CYCLE; PATHOGENESIS; PERITONEAL FLUID; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UTERINE TUBE LIGATION;

EID: 37849189894     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.01.005     Document Type: Article

References (36)

1. Barcz E., KamiÄski P., and Marianowski L. Role of cytokines in pathogenesis of endometriosis. Med Sci Monit 6 (2000) 1042-1046
2. Mahnke J.L., Dawood M.Y., and Huang J.C. Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil Steril 73 (2000) 166-170
3. Barcz E., Rozewska E.S., Kaminski P., Demkow U., Bobrowska K., and Marianowski L. Angiogenic activity and IL-8 concentrations in peritoneal fluid and sera in endometriosis. Int J Gynaecol Obstet 79 (2002) 229-235
4. Punnonen J., Teisala K., Ranta H., Bennett B., and Punnonen R. Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis. Am J Obstet Gynecol 174 (1996) 1522-1526
5. Matarese G., Alviggi C., Sanna V., et al. Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab 85 (2000) 2483-2487
6. Bedaiwy M.A., Falcone T., Sharma R.K., et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 17 (2002) 426-431
7. Lebovic D.I., Mueller M.D., and Taylor R.N. Immunobiology of endometriosis. Fertil Steril 75 (2001) 1-10
8. Umesaki N., Tanaka T., Miyama M., Mizuno K., Kawamura N., and Ogita S. Increased natural killer cell activities in patients treated with gonadotropin releasing hormone agonist. Gynecol Obstet Invest 48 (1999) 66-68
9. Matalliotakis I., Neonaki M., Zolindaki A., Hassan E., Georgoulias V., and Koumantakis E. Changes in immunologic variables (TNF-a, sCD8 and sCD4) during danazol treatment in patients with endometriosis. Int J Fertil Womens Med 42 (1997) 211-214
10. Ho H.N., Wu M.Y., and Yang Y.S. Peritoneal cellular immunity and endometriosis. Am J Reprod Immunol 38 (1997) 400-402
11. Perera L.P. Interleukin 15: its role in inflammation and immunity. Arch Immunol Ther Exp (Warsz) 48 (2000) 457-464
12. Waldmann T.A. IL-15 in the life and death of lymphocytes: immunotherapeutic implications. Trends Mol Med 9 (2003) 517-521
13. Fehniger T.A., and Caligiuri M.A. Interleukin 15: biology and relevance to human disease. Blood 97 (2001) 14-32
14. Ohteki T. Critical role for IL-15 in innate immunity. Curr Mol Med 2 (2002) 371-380
15. Okada S., Okada H., Sanezumi M., Nakajima T., Yasuda K., and Kanzaki H. Expression of interleukin-15 in human endometrium and decidua. Mol Hum Reprod 6 (2000) 75-80
16. Kitaya K., Yasuda J., Yagi I., Tada Y., Fushiki S., and Honjo H. IL-15 expression at human endometrium and decidua. Biol Reprod 63 (2000) 683-687
17. Dunn C.L., Critchley H.O., and Kelly R.W. IL-15 regulation in human endometrial stromal cells. J Clin Endocrinol Metab 87 (2002) 1898-1901
18. Okada H., Nakajima T., Sanezumi M., Ikuta A., Yasuda K., and Kanzaki H. Progesterone enhances interleukin-15 production in human endometrial stromal cells in vitro. J Clin Endocrinol Metab 85 (2000) 4765-4770
19. Chegini N., Roberts M., and Ripps B. Differential expression of interleukins (IL)-13 and IL-15 in ectopic and eutopic endometrium of women with endometriosis and normal fertile women. Am J Reprod Immunol 49 (2003) 75-83
20. Arici A., Matalliotakis I., Goumenou A., et al. Increased levels of interleukin-15 in the peritoneal fluid of women with endometriosis: inverse correlation with stage and depth of invasion. Hum Reprod 18 (2003) 429-432
21. Yoshikai Y., and Nishimura H. The role of interleukin 15 in mounting an immune response against microbial infections. Microbes Infect 2 (2000) 381-389
22. Lu J., Giuntoli II R.L., Omiya R., Kobayashi H., Kennedy R., and Celis E. Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes. Clin Cancer Res 8 (2002) 3877-3884
23. Garzetti G.G., Ciavattini A., Provinciali M., Muzzioli M., Di Stefano G., and Fabris N. Natural killer activity in stage III and IV endometriosis: impaired cytotoxicity and retained lymphokine responsiveness of natural killer cells. Gynecol Endocrinol 9 (1995) 125-130
24. Garzetti G.G., Ciavattini A., Provinciali M., Amati M., Muzzioli M., and Governa M. Decrease in peripheral blood polymorphonuclear leukocyte chemotactic index in endometriosis: role of prostaglandin E2 release. Obstet Gynecol 91 (1998) 25-29
25. Prlic M., Blazar B.R., Farrar M.A., and Jameson S.C. In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med 197 (2003) 967-976
26. Cooper M.A., Bush J.E., Fehniger T.A., et al. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 100 (2002) 3633-3638
27. Naora H., and Gougeon M.L. Enhanced survival and potent expansion of the natural killer cell population of HIV-infected individuals by exogenous interleukin-15. Immunol Lett 68 (1999) 359-367
28. Sun R., Fan J., Wei H., Zhang C., and Tian Z. Use of interleukin-15 for preparation of adherent NK cells from human peripheral blood: comparison with interleukin-2. J Immunol Meth 279 (2003) 79-90
29. Kobayashi H., Carrasquillo J.A., Paik C.H., Waldmann T.A., and Tagaya Y. Differences of biodistribution, pharmacokinetics, and tumor targeting between interleukins 2 and 15. Cancer Res 60 (2000) 3577-3583
30. Mizuno Y., Takada H., Nomura A., et al. Th1 and Th1-inducing cytokines in Salmonella infection. Clin Exp Immunol 131 (2003) 111-117
31. Strengell M., Sareneva T., Foster D., Julkunen I., and Matikainen S. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J Immunol 169 (2002) 3600-3605
32. Fehniger T.A., Cooper M.A., and Caligiuri M.A. Interleukin-2 and interleukin-15: immunotherapy for cancer. Cytokine Growth Factor Rev 13 (2002) 169-183
33. Wu M.Y., and Ho H.N. The role of cytokines in endometriosis. Am J Reprod Immunol 49 (2003) 285-296
34. Pizzo A., Salmeri F.M., Ardita F.V., Sofo V., Tripepi M., and Marsico S. Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol Obstet Invest 54 (2002) 82-87
35. Lugering N., Kucharzik T., Maaser C., Kraft M., and Domschke W. Interleukin-15 strongly inhibits interleukin-8 and monocyte chemoattractant protein-1 production in human colonic epithelial cells. Immunology 98 (1999) 504-509
36. Alleva D.G., Kaser S.B., Monroy M.A., Fenton M.J., and Beller D.I. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J Immunol 159 (1997) 2941-2951